Phibro Animal Health (PAHC) Competitors $18.02 +0.82 (+4.77%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAHC vs. MOR, SWTX, CRNX, CPRX, PTGX, VKTX, SRRK, IMVT, HCM, and ALVOShould you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include MorphoSys (MOR), SpringWorks Therapeutics (SWTX), Crinetics Pharmaceuticals (CRNX), Catalyst Pharmaceuticals (CPRX), Protagonist Therapeutics (PTGX), Viking Therapeutics (VKTX), Scholar Rock (SRRK), Immunovant (IMVT), HUTCHMED (HCM), and Alvotech (ALVO). These companies are all part of the "pharmaceutical products" industry. Phibro Animal Health vs. MorphoSys SpringWorks Therapeutics Crinetics Pharmaceuticals Catalyst Pharmaceuticals Protagonist Therapeutics Viking Therapeutics Scholar Rock Immunovant HUTCHMED Alvotech Phibro Animal Health (NASDAQ:PAHC) and MorphoSys (NASDAQ:MOR) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, community ranking, dividends, valuation, earnings and profitability. Is PAHC or MOR more profitable? Phibro Animal Health has a net margin of 1.75% compared to MorphoSys' net margin of -226.79%. Phibro Animal Health's return on equity of 25.35% beat MorphoSys' return on equity.Company Net Margins Return on Equity Return on Assets Phibro Animal Health1.75% 25.35% 6.21% MorphoSys -226.79%-694.31%-22.55% Which has more risk and volatility, PAHC or MOR? Phibro Animal Health has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, MorphoSys has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Do analysts prefer PAHC or MOR? Phibro Animal Health presently has a consensus target price of $19.75, indicating a potential upside of 11.80%. Given Phibro Animal Health's stronger consensus rating and higher possible upside, analysts plainly believe Phibro Animal Health is more favorable than MorphoSys.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phibro Animal Health 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50MorphoSys 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor PAHC or MOR? Phibro Animal Health received 291 more outperform votes than MorphoSys when rated by MarketBeat users. Likewise, 59.85% of users gave Phibro Animal Health an outperform vote while only 38.46% of users gave MorphoSys an outperform vote. CompanyUnderperformOutperformPhibro Animal HealthOutperform Votes31659.85% Underperform Votes21240.15% MorphoSysOutperform Votes2538.46% Underperform Votes4061.54% Do insiders & institutionals have more ownership in PAHC or MOR? 99.3% of Phibro Animal Health shares are held by institutional investors. Comparatively, 18.4% of MorphoSys shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by insiders. Comparatively, 0.1% of MorphoSys shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has higher valuation & earnings, PAHC or MOR? Phibro Animal Health has higher revenue and earnings than MorphoSys. MorphoSys is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhibro Animal Health$1.11B0.65$2.42M$0.4836.80MorphoSys$238.28M11.99-$205.35M-$3.48-5.45 Does the media refer more to PAHC or MOR? In the previous week, Phibro Animal Health had 6 more articles in the media than MorphoSys. MarketBeat recorded 6 mentions for Phibro Animal Health and 0 mentions for MorphoSys. Phibro Animal Health's average media sentiment score of 1.11 beat MorphoSys' score of 0.00 indicating that Phibro Animal Health is being referred to more favorably in the media. Company Overall Sentiment Phibro Animal Health Positive MorphoSys Neutral SummaryPhibro Animal Health beats MorphoSys on 15 of the 17 factors compared between the two stocks. Get Phibro Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAHC vs. The Competition Export to ExcelMetricPhibro Animal HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$713.06M$6.55B$5.39B$7.63BDividend Yield2.78%3.21%5.44%4.33%P/E Ratio36.687.0722.0918.17Price / Sales0.65261.56391.22105.10Price / Cash10.8765.6738.2034.62Price / Book2.906.396.764.19Net Income$2.42M$142.49M$3.21B$247.59M7 Day Performance2.17%7.05%4.53%4.95%1 Month Performance-19.92%-8.52%-6.55%-4.69%1 Year Performance40.64%-2.25%15.81%3.76% Phibro Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAHCPhibro Animal Health3.9156 of 5 stars$18.02+4.8%$19.75+9.6%+26.4%$729.86M$1.11B37.541,860Positive NewsMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730SWTXSpringWorks Therapeutics2.388 of 5 stars$37.46+2.7%$73.20+95.4%-6.2%$2.81B$191.59M-10.76230Upcoming EarningsNews CoveragePositive NewsCRNXCrinetics Pharmaceuticals3.5739 of 5 stars$29.78+2.3%$73.00+145.1%-26.8%$2.77B$1.04M-7.98210Positive NewsCPRXCatalyst Pharmaceuticals4.6072 of 5 stars$22.80+3.4%$32.29+41.6%+57.0%$2.77B$491.73M19.3280Positive NewsPTGXProtagonist Therapeutics3.7883 of 5 stars$45.03+5.7%$65.44+45.3%+71.9%$2.76B$434.43M16.93120Positive NewsVKTXViking Therapeutics4.2918 of 5 stars$24.57+10.6%$89.75+265.3%-60.2%$2.76BN/A-24.5720Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeSRRKScholar Rock3.5594 of 5 stars$28.93+3.3%$42.67+47.5%+120.3%$2.74B$33.19M-12.31140News CoveragePositive NewsIMVTImmunovant1.9366 of 5 stars$15.43+5.1%$41.00+165.7%-49.5%$2.62BN/A-5.89120Analyst ForecastNews CoveragePositive NewsGap UpHCMHUTCHMED1.3165 of 5 stars$14.89+8.5%$19.00+27.6%-16.7%$2.60B$630.20M0.001,988Gap UpALVOAlvotech1.7105 of 5 stars$8.53-3.0%$18.00+111.0%-37.6%$2.57B$489.68M-4.614 Related Companies and Tools Related Companies MOR Competitors SWTX Competitors CRNX Competitors CPRX Competitors PTGX Competitors VKTX Competitors SRRK Competitors IMVT Competitors HCM Competitors ALVO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAHC) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAHC Stock Free PAHC Stock Alerts